These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 16354277)

  • 1. Therapeutic apheresis--state of the art in the year 2005.
    Bosch T
    Ther Apher Dial; 2005 Dec; 9(6):459-68. PubMed ID: 16354277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in therapeutic apheresis.
    Bosch T
    J Artif Organs; 2003; 6(1):1-8. PubMed ID: 14598117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic apheresis: selective methods].
    Kes P; Basić-Jukić N; Jurić I; Ratković-Gusić I
    Acta Med Croatica; 2008; 62 Suppl 1():49-59. PubMed ID: 18578333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. World apheresis registry report.
    Stegmayr B; Ptak J; Wikström B
    Transfus Apher Sci; 2007 Feb; 36(1):13-6. PubMed ID: 17234456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Italian Registry of Pediatric Therapeutic Apheresis: a report on activity during 2005.
    De Silvestro G; Tison T; Vicarioto M; Bagatella P; Stefanutti C; Marson P
    J Clin Apher; 2009; 24(1):1-5. PubMed ID: 19073013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RheoNet registry analysis of rheopheresis for microcirculatory disorders with a focus on age-related macular degeneration.
    Klingel R; Fassbender C; Heibges A; Koch F; Nasemann J; Engelmann K; Carl T; Meinke M; Erdtracht B
    Ther Apher Dial; 2010 Jun; 14(3):276-86. PubMed ID: 20609179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical studies to implement Rheopheresis for age-related macular degeneration guided by evidence-based-medicine.
    Klingel R; Fassbender C; Fassbender T; Göhlen B
    Transfus Apher Sci; 2003 Aug; 29(1):71-84. PubMed ID: 12877897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-Induced extracorporeal low-density lipoprotein precipitation apheresis: a new therapeutic concept in the treatment of sudden hearing loss.
    Suckfüll M
    Ther Apher; 2001 Oct; 5(5):377-83. PubMed ID: 11778923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia.
    Otto C; Berster J; Otto B; Parhofer KG
    J Clin Apher; 2007; 22(6):301-5. PubMed ID: 17935245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quo vadis haemapheresis. Current developments in haemapheresis.
    Borberg H
    Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WAA apheresis registry in the Czech Republic: two centers experience.
    Bláha M; Pták J; Cáp J; Ceeová V; Masín V; Filip S; Blazek M
    Transfus Apher Sci; 2009 Aug; 41(1):27-31. PubMed ID: 19524488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Italian Registry for Therapeutic Apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology.
    Passalacqua S; Staffolani E; Busnach G; Roccatello D; Pasquali S; Cappelli P; Liuzzo G;
    J Clin Apher; 2005 Jul; 20(2):101-6. PubMed ID: 15880354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies.
    Kumlien G; Ullström L; Losvall A; Persson LG; Tydén G
    Transfusion; 2006 Sep; 46(9):1568-75. PubMed ID: 16965585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a national on-line registry for apheresis in Korea.
    Song EY; Yoon JH; Lee JW; Park CW; Kwon SW; Kim DW; Lim YA; Kim HO; Han KS
    Transfus Apher Sci; 2008 Apr; 38(2):93-100. PubMed ID: 18359274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic apheresis in low weight patients: technical feasibility, tolerance, compliance, and risks.
    Stefanutti C; Lanti A; Di Giacomo S; Mareri M; De Lorenzo F; Landolfo A; Isacchi G
    Transfus Apher Sci; 2004 Aug; 31(1):3-10. PubMed ID: 15294188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic apheresis in Sweden: update of epidemiology and adverse events.
    Norda R; Stegmayr BG;
    Transfus Apher Sci; 2003 Oct; 29(2):159-66. PubMed ID: 12941356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of hyperviscosity by apheresis.
    Zarkovic M; Kwaan HC
    Semin Thromb Hemost; 2003 Oct; 29(5):535-42. PubMed ID: 14631553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of blood purification techniques.
    Stegmayr BG
    Transfus Apher Sci; 2005 Apr; 32(2):209-20. PubMed ID: 15784456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical considerations for planning a therapeutic apheresis procedure.
    Shelat SG
    Am J Med; 2010 Sep; 123(9):777-84. PubMed ID: 20541168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Canadian apheresis registry.
    Rock G; Clark B; Sutton D; ;
    Transfus Apher Sci; 2003 Oct; 29(2):167-77. PubMed ID: 12941357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.